Hepatitis C

Latest News

April 23rd 2012

Evaluation of Human Immunodeficiency Virus and Hepatitis C Telemedicine Clinics

By Hemen N. Saifu, MPH, Steven M. Asch, MD, MPH, Matthew Bidwell Goetz, MD

In an integrated health system, human immunodeficiency virus and hepatitis C telemedicine clinics are associated with improved access, high patient satisfaction, and reduction in health visitâ€œrelated time.

April 5th 2012

Drug Spending Levels Off, But Not For The Usual Reasons

March 7th 2012

More Patients Relapse in Gilead Hepatitis C Trial

February 22nd 2012

Teva Is Said to Pay $250 Million to End Nevada Colonoscopy Hepatitis Cases

February 10th 2012

FDA: HCV Drug Interferes With HIV Meds

Dr. David Winston Urges Physicians To Routinely Screen for Hepatitis C

January 12th 2012

Novel Hepatitis C Vaccine Induces T Cell Responses

January 6th 2012

Recap: The 53rd American Society of Hematology Annual Meeting and Exposition

December 19th 2011

Hepatitis C Birth Cohort Screening is Cost-Effective

November 7th 2011

Absenteeism and Productivity Among Employees Being Treated for Hepatitis C

ByRichard A. Brook, MS, MBA,Nathan L. Kleinman, PhD,Jun Su, MD, MSc,Patricia K. Corey-Lisle, PhD,Uchenna H. Iloeje, MD, MPH

October 10th 2011

Employees with hepatitis C (HCV) who underwent existing treatments had more absences and higher indirect costs than HCVinfected employees who did not undergo treatment.

HCV Screening Practices and Prevalence in an MCO, 2000-2007

ByDouglas W. Roblin, PhD,Bryce D. Smith, PhD,Cindy M. Weinbaum, MD, MPH,Miriam E. Sabin, PhD

August 5th 2011

HCV screening and prevalence estimates, unadjusted and adjusted for HCV risk factors, are examined in this 8-year observational study of a managed care organization.

Case 2: Emerging Therapeutic Options in Hepatitis C Virus Infection (CE)

Byby Fred Poordad, MD,Vandana Khungar, MD, MSc

April 26th 2011

Hepatitis C

Latest News

Dr. David Winston Urges Physicians To Routinely Screen for Hepatitis C

Novel Hepatitis C Vaccine Induces T Cell Responses

Recap: The 53rd American Society of Hematology Annual Meeting and Exposition

Hepatitis C Birth Cohort Screening is Cost-Effective

Absenteeism and Productivity Among Employees Being Treated for Hepatitis C

HCV Screening Practices and Prevalence in an MCO, 2000-2007

Case 2: Emerging Therapeutic Options in Hepatitis C Virus Infection (CE)

Trending on AJMC

Delayed Dupilumab Raises Asthma Costs 32%: Nicola Hanania, MD

A Patient-Centered Reconstruction of 340B in Oncology: Transparency, Equity, and Site-of-Care Accountability

Aspirin's CRC Benefit Narrows to PIK3CA Exon 9/20 Mutations

Designing Effective Value-Based Oncology Models: Lalan Wilfong, MD

Risankizumab Outperforms Deucravacitinib in Moderate Plaque Psoriasis